Clinical Trial

A Study of SYH2069 Injection in Healthy Participants

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the safety and tolerability of single and multiple doses of SYH2069 Injection in healthy participants.
Trial Details
NCT Number NCT07736391
Lead Sponsor CSPC Ouyi Pharmaceutical Co., Ltd.
Conditions Overweight or Obesity, Diabetes
Enrollment 104 participants
Start Date 2026-01-10
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-30